Clinical Trials Conditions Pets 
NORML
JANUARY 18, 2019
House lawmakers introduced The Medical Cannabis Research Act of 2019 (HR 601), to facilitate federally-approved clinical trials involving cannabis. Senator Anna Wishart (D) has re-introduced legislation, LB 110, to allow qualifying patients with certain debilitating conditions to use and safely access medical cannabis.
CannaMD
MAY 12, 2021
It’s well known that marijuana can be an agent for appetite stimulation, making it a valuable therapy for mitigating the weight loss sometimes associated with conditions such as HIV/AIDS and cancer. The condition can lead to weight gain and obesity. Binges are often followed by feelings of guilt and shame.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Joint Blog
JUNE 20, 2019
Until recently, Blake Armstrong was a pet owner like any other. After seeing a huge improvement in Rosie’s quality of life, Blake launched Cannabis Supplements For Pets ; a website for pet owners covering the health benefits of CBD with reviews of leading CBD pet brands. And that’s exactly what we did,” said Blake. “We
The Blunt Truth
DECEMBER 23, 2020
These companies faced administrative actions by the FTC for “making a wide range of scientifically unsupported claims about their ability to treat serious health conditions,” such as cancer, Alzheimer’s disease, and pain relief. The warning letters address the illegal marketing of unapproved CBD products claiming to treat medical conditions.
Cannabis Law Report
NOVEMBER 19, 2021
It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. Pet Insurance. MAPS PBC is a Public Benefit Corporation, with a dual mandate to generate shareholder value and public benefit.
Project CBD
FEBRUARY 28, 2023
Despite the companies’ submitting the required data demonstrating the “reasonable expectation of safety under the recommended conditions of use,” the FDA rejected the applications, citing the drug preclusion clause. The labs analyzed 35 oils, 40 topical products, 40 edibles, 22 beverages, 55 pet products, and 29 coffee or tea products.
Cannabis Law Report
DECEMBER 28, 2021
The users of CBD products claim to have seen improvement in different medical conditions, including depression, chronic pain, insomnia, epilepsy, anxiety, etc., This is because Epidiolex has been proven an effective treatment after going through various clinical trials. after its consumption. Myth # 5: CBD is Only for Adults.
Expert insights. Personalized for you.
190 
Let's personalize your content